ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
In retirement, choosing between Sp500 and Total Market matters. This guide outlines criteria to select the better fit for your horizon and risk profile.
28,409 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Goldman Sachs' latest research paints a paradox: trillions are pouring into AI infrastructure, but returns remain mur...
A watchdog group alleges ethics breaches by the FCC chair tied to a media oversight push. Bar associations are review...
NATO defense budgets surged to fresh records as members commit to larger, longer-term modernization. Three ETFs offer...
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
Investors are eyeing a nuclear-powered future, but is Nuscale Power really the smartest investment today? This guide ...
Copper-focused ETFs have outperformed in recent months, but a softer global factory backdrop could test demand. Here'...
Iran pushes differing versions of an interim deal with the United States as negotiators race against a looming deadli...
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
A prominent market strategist argues the brutal tech and crypto rout may be nearing a bottom as risk assets stabilize...
A chip-focused fund jumps roughly 80% in 2026, signaling investors are seeking broader exposure to AI infrastructure ...
The 30-year fixed mortgage rate falls below 6% for the first time since 2022, shaking up affordability for buyers as ...